NUCYNTA - 50458-864-01 - (tapentadol hydrochloride)

Alphabetical Index


Drug Information of NUCYNTA

Product NDC: 50458-864
Proprietary Name: NUCYNTA
Non Proprietary Name: tapentadol hydrochloride
Active Ingredient(s): 250    mg/1 & nbsp;   tapentadol hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of NUCYNTA

Product NDC: 50458-864
Labeler Name: Janssen Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA200533
Marketing Category: NDA
Start Marketing Date: 20110825

Package Information of NUCYNTA

Package NDC: 50458-864-01
Package Description: 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-864-01)

NDC Information of NUCYNTA

NDC Code 50458-864-01
Proprietary Name NUCYNTA
Package Description 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-864-01)
Product NDC 50458-864
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name tapentadol hydrochloride
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20110825
Marketing Category Name NDA
Labeler Name Janssen Pharmaceuticals, Inc.
Substance Name TAPENTADOL HYDROCHLORIDE
Strength Number 250
Strength Unit mg/1
Pharmaceutical Classes Opioid Agonist [EPC],Opioid Agonists [MoA]

Complete Information of NUCYNTA


General Information